Gil, 2007 n= 27,259 propensity score-matched pairs; Ontario, Canada residents ... of antipsychotics per Ontario Drug Benefit program after cohort entry; olanzapine, quetiapine, or risperidone ...
subcutaneous long-acting injection of the atypical antipsychotic olanzapine for the treatment of schizophrenia. This is the second drug within the partnership with Teva that uses Medincell’s co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback